Mapping the trajectory from pre-COPD to COPD: predictive value of symptoms, imaging, and physiologic abnormalities
- 23 January 2026
- journal article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (3) , 468-471
Abstract
No abstract availableFunding Information
- National Institutes of Health (K23HL151751)
- National Institutes of Health (K24HL138188)
- Solovy Award for Advancement
- Respiratory Health Association (NCT00608764)
- National Heart, Lung, and Blood Institute (U01HL089897)
- National Heart, Lung, and Blood Institute (U01HL089856)
- COPD Foundation
- Industry Advisory Committee
- AstraZeneca
- Bayer Pharmaceuticals
- Boehringer-Ingelheim
- GlaxoSmithKline
This publication has 20 references indexed in Scilit:
- Bronchodilator responsiveness and future chronic airflow obstruction: a multinational longitudinal studyeClinicalMedicine, 2025
- Early Diagnosis and Treatment of COPD and Asthma — A Randomized, Controlled TrialNew England Journal of Medicine, 2024
- A reference equation for lung volume on computed tomography in Japanese middle-aged and elderly adultsRespiratory Investigation, 2023
- Isolated small airways obstruction predicts future chronic airflow obstruction: a multinational longitudinal studyBMJ Open Respiratory Research, 2023
- Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved SpirometryJAMA, 2023
- Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2022
- Screening for Chronic Obstructive Pulmonary DiseaseJAMA, 2022
- From GOLD 0 to Pre-COPDAmerican Journal of Respiratory and Critical Care Medicine, 2021
- Tiotropium in Early-Stage Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2017
- Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progressionNature Medicine, 2012